PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Mental Health Dementia Alzheimer's Disease

Caffeine might have a protective role against Alzheimer’s disease

by Vladimir Hedrih
October 9, 2024
Reading Time: 4 mins read
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Add as a preferred source on GoogleFollow on Google News

A study of individuals with mild cognitive impairment and Alzheimer’s disease in France found that participants who consumed less caffeine had 2.49 times higher odds of having amnestic mild cognitive impairment and worse levels of specific cerebrospinal fluid biomarkers associated with Alzheimer’s. The study was part of the ongoing BALTAZAR cohort and was published in the journal Alzheimer’s & Dementia.

Alzheimer’s disease is a progressive neurodegenerative disorder that profoundly affects memory, thinking, and behavior. It is the most common cause of dementia, particularly in older adults, though in rare cases, it can develop in younger people. Alzheimer’s disease is characterized by the buildup of abnormal clumps of protein fragments called amyloid-beta plaques and twisted fibers of tau protein, known as tau tangles, in the brain. These proteins disrupt the communication between brain cells and eventually lead to their death, causing cognitive decline and memory loss.

Early symptoms of Alzheimer’s often include difficulty remembering recent events or conversations. As the disease progresses, more severe symptoms emerge, including disorientation, confusion, difficulty speaking or writing, and changes in personality or mood. In advanced stages, individuals lose the ability to carry out everyday tasks, such as cooking or dressing, and require full-time care. Currently, there is no cure for Alzheimer’s, though there are treatments aimed at temporarily alleviating symptoms.

Study author David Blum and his colleagues wanted to explore the relationship between habitual caffeine intake and certain biomarkers related to Alzheimer’s disease in the cerebrospinal fluid—the fluid that surrounds the brain and spinal cord. These biomarkers include amyloid-beta and tau proteins, which are used to detect and monitor the progression of Alzheimer’s disease. The team also examined the differences in caffeine consumption between individuals with mild cognitive impairment, a condition that often precedes Alzheimer’s, and those who had already been diagnosed with Alzheimer’s disease.

Free daily newsletter

Don’t miss the next big psychology finding

Every morning, PsyPost sends a short briefing on the most interesting new peer-reviewed research in psychology and neuroscience.

✓ Free ✓ One email a day ✓ Unsubscribe anytime

The study was part of the BALTAZAR cohort, a large, ongoing research project focusing on individuals with mild cognitive impairment and Alzheimer’s disease. The researchers analyzed 263 participants: 147 with mild cognitive impairment and 116 with Alzheimer’s disease. Mild cognitive impairment (MCI) participants were further categorized into two subtypes: amnestic mild cognitive impairment (aMCI), where memory loss is the primary issue, and non-amnestic mild cognitive impairment (naMCI), where other cognitive functions are primarily affected.

Participants in the study completed a detailed survey about their daily consumption of caffeine-containing items, such as coffee, tea, chocolate, or sodas. This survey was designed to assess each participant’s caffeine intake, which was calculated in milligrams per day. Alongside the caffeine survey, participants also provided blood samples and cerebrospinal fluid samples.

Cerebrospinal fluid was analyzed for key biomarkers of Alzheimer’s disease, including total tau (tau), phosphorylated tau (p-tau181), amyloid-beta 1-42 (Aβ1-42), and amyloid-beta 1-40 (Aβ1-40). Elevated levels of tau and p-tau181 indicate brain cell damage and neurofibrillary tangles, which are associated with Alzheimer’s disease. On the other hand, lower levels of Aβ42, particularly in relation to Aβ40, are associated with the buildup of amyloid plaques, another indicator of Alzheimer’s disease progression.

Participants were categorized into two groups based on their caffeine consumption: a “low caffeine” group, with daily intake below 216 milligrams, and a “high caffeine” group, with daily intake above this amount. The researchers then compared the cognitive status and biomarker levels between these two groups.

Results showed that individuals who consumed lower amounts of caffeine had significantly higher odds of being categorized as amnestic, meaning they experienced memory-related impairments. Specifically, the odds of being diagnosed with amnestic mild cognitive impairment or Alzheimer’s disease were 2.49 times higher for participants with lower caffeine consumption compared to those with higher intake. This suggests a potential protective effect of caffeine on memory, particularly in individuals at risk for or already diagnosed with Alzheimer’s disease.

When the researchers looked specifically at participants with mild cognitive impairment, they found that those with lower caffeine intake had 2.72 times higher odds of being classified as amnestic rather than non-amnestic. This finding suggests that caffeine consumption might be particularly relevant for memory-related issues.

In addition to cognitive outcomes, the study also found significant differences in cerebrospinal fluid biomarkers between high and low caffeine consumers. Participants who consumed less caffeine tended to have lower levels of Aβ42 and lower Aβ42/Aβ40 and Aβ42/p-tau181 ratios. These lower levels and ratios of Aβ42 are typically associated with increased amyloid plaque formation in the brain, a major hallmark of Alzheimer’s disease. The results suggest that lower caffeine intake might be linked to greater amyloid burden, which is associated with faster disease progression.

“Our data support an association of lower caffeine consumption with a higher risk of being amnestic as well as with deleterious changes in CSF [cerebrospinal fluid] biomarkers of MCI [mild cognitive impairment] and AD [Alzheimer’s disease] patients,” the study authors concluded.

The study sheds light on the association between caffeine consumption and the symptoms of Alzheimer’s disease. However, it should be noted that the design of this study does not allow for any cause-and-effect conclusions to be drawn from the data. While it is possible that caffeine might have protective effects against the symptoms of Alzheimer’s, it is also possible that individuals in better cognitive health simply consume more caffeinated beverages (e.g., because they are better able to take care of themselves, including being better able to obtain and prepare the beverages they prefer).

The paper, “Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer’s disease: A BALTAZAR cohort study,” was authored by David Blum, Emeline Cailliau, Hélène Béhal, Jean-Sébastien Vidal, Constance Delaby, Luc Buée, Bernadette Allinquant, Audrey Gabelle, Stéphanie Bombois, Sylvain Lehmann, Susanna Schraen-Maschke, and Olivier Hanon.

TweetSendScanShareSendPin6ShareShareShareShareShare

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • Greater male variability may help explain persistent gender gaps in hiring, study suggests
  • The best conversations may follow a hidden mathematical rhythm called pink noise, according to new psychology research
  • Irritable kids are hard to parent, and that strain may show up years later, new study suggests
  • Psychology’s tools for measuring masculinity lean heavily toward the negative, review finds
  • The link between genes and kids’ IQ shifts as they grow up, large study finds

Science of Money

  • Can brain scans help retailers predict grocery sales?
  • Why combining four small coupons feels better than getting one big discount
  • Does menopause alter how women handle financial risk?
  • What lottery winners reveal about how different income groups spend, save, and work
  • Commanding bosses may drive stressed employees to hide what they know

Recent

  • A $1 LSD booklet from 1967 anticipated much of today’s psychedelic safety advice, study suggests
  • Paid sexual exchanges are far more common among young adults than once thought, new study suggests
  • Tau builds up faster in people who develop Alzheimer’s before 65, large PET study finds
  • Smartphone game shows promise as an add-on to antidepressants
  • AI-written peer reviews outscored top human experts in blind comparisons, Harvard working paper finds
  • Brain scans reveal structural differences in treatment-resistant schizophrenia
  • Being near a romantic partner may help the body regulate blood sugar, temperature, and stress
  • Bedroom temperature may be a hidden drag on productivity, study suggests
  • Insecure attachment linked to reduced well-being in bisexual young adults
  • People project a specific racial identity onto artificial intelligence, study finds

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • FAQ

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc